JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gray, W. D.
Right arrow Articles by Shanahan, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gray, W. D.
Right arrow Articles by Shanahan, R. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 139, Issue 3, 350-360, 1963
Copyright © 1963 by American Society for Pharmacology and Experimental Therapeutics


THE MECHANISM OF THE ANTAGONISTIC ACTION OF RESERPINE ON THE ANTICONVULSANT EFFECT OF INHIBITORS OF CARBONIC ANHYDRASE

William D. Gray 1, Charles E. Rauh 1, and Robert W. Shanahan 1

1 Department of Experimental Pharmacology, Experimental Therapeutics Research Section, Lederle Laboratories Division, American Cyanamid Co., Pearl River, New York

Antagonism of the anticonvulsant action of inhibitors of carbonic anhydrase in mice by reserpine was shown not to be due to any effect of this agent on brain with respect to 1) the concentration of inhibitor, 2) the activity of carbonic anhydrase, 3) the intracellular localization of enzyme and inhibitor, or 4) the interaction of enzyme and inhibitor. Competition between agents with opposing actions on the excitability of brain was also excluded as a mode of action. Because methyldopa and tetrabenazine were also able to antagonize the action of methazolamide, depletion of brain amines appeared to be the causative factor. Since the anticonvulsant action of methazolamide could be restored by pretreatment with monoamine oxidase inhibitors or by the administration of dihydroxyphenylalanine (dopa), but not by nearly equivalent amounts of tryptophan or 5-hydroxytryptophan, it was concluded that the presence of catecholamines in brain is necessary in order for inhibitors of carbonic anhydrase to exhibit their anticonvulsant effect.

Submitted on August 24, 1962
Accepted on December 3, 1962







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1963 by the American Society for Pharmacology and Experimental Therapeutics.